Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ken Kawaura is active.

Publication


Featured researches published by Ken Kawaura.


Journal of International Medical Research | 2006

Traditional Chinese Medicine and Kampo: A Review from the Distant past for the Future

F Yu; Takashi Takahashi; Junji Moriya; Ken Kawaura; J Yamakawa; K Kusaka; T Itoh; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda

Traditional Chinese medicine (TCM) is a complete system of healing that developed in China about 3000 years ago, and includes herbal medicine, acupuncture, moxibustion and massage, etc. In recent decades the use of TCM has become more popular in China and throughout the world. Traditional Japanese medicine has been used for 1500 years and includes Kampo-yaku (herbal medicine), acupuncture and acupressure. Kampo is now widely practised in Japan and is fully integrated into the modern health-care system. Kampo is based on TCM but has been adapted to Japanese culture. In this paper we review the history and characteristics of TCM and traditional Japanese medicine, i.e. the selection of traditional Chinese herbal medicine treatments based on differential diagnosis, and treatment formulations specific for the ‘Sho’ (the patients symptoms at a given moment) of Japanese Kampo - and look at the prospects for these forms of medicine.


Journal of Gastroenterology and Hepatology | 2003

Herpes simplex esophagitis from 1307 autopsy cases

Tohru Itoh; Takashi Takahashi; K Kusaka; Ken Kawaura; Yoshiaki Nakagawa; J Yamakawa; Tsugiyasu Kanda

Background and Aims:  The aim of the present study was to clarify relationship between macroscopic and microscopic features of herpes simplex esophagitis (HSE), and localization of herpes simplex virus type 1 (HSV‐1)‐infected cells in esophageal lesions from autopsy cases of histopathologically proven HSE.


Journal of International Medical Research | 2004

Effect of the Serotonin Blocker Sarpogrelate on Circulating Interleukin-18 Levels in Patients with Diabetes and Arteriosclerosis Obliterans

J Yamakawa; Takashi Takahashi; Seiichiro Saegusa; Junji Moriya; T Itoh; K Kusaka; Ken Kawaura; Xq Wang; Tsugiyasu Kanda

We aimed to evaluate the effect of treatment with sarpogrelate, a serotonin 2A receptor antagonist, on circulating interleukin (IL)-18 levels in patients with diabetes and arteriosclerosis obliterans. Patients received sarpogrelate (100 mg 3 times daily) for 2 months. We evaluated the degree of cryaesthesia (a feeling of cold in the foot and toes) as the clinical outcome, and measured circulating IL-18, IL-6 and lipid protein concentrations. An improvement in clinical outcome occurred after initiation of sarpogrelate therapy;a significant decrease in IL-18 levels was observed after 2 months of therapy. Levels of IL-6 and lipid proteins, including triglyceride, total cholesterol and high-density lipoprotein cholesterol, were not significantly altered by treatment. Our data suggest that by reducing circulating IL-18 levels, sarpogrelate treatment may contribute to the inhibition of arteriosclerosis obliterans progression in patients with diabetes.


Journal of International Medical Research | 2004

Panic attack symptoms in a patient with left temporal lobe epilepsy.

Seiichiro Saegusa; Takashi Takahashi; Junji Moriya; J Yamakawa; T Itoh; K Kusaka; Ken Kawaura; Tsugiyasu Kanda

We describe a 56-year-old woman with left temporal lobe epilepsy who developed symptoms of a panic attack. Owing to normal electroencephalography and brain magnetic resonance imaging results, she was initially diagnosed as suffering from panic attacks and treated for anxiety neurosis. The symptoms persisted and she was re-examined in our department. An interictal electroencephalogram showed paroxysmal spike waves in the left mesial temporal lobe region and this was the basis for a diagnosis of left temporal lobe epilepsy. This report suggests that left temporal lobe epilepsy should be considered as the differential diagnosis when patients frequently complain of fear or anxiety.


Journal of International Medical Research | 2003

Spontaneously Identified Gastric Sarcoidosis: A Report of Three Cases

Ken Kawaura; Takashi Takahashi; K Kusaka; J Yamakawa; T Itoh; Tsugiyasu Kanda

Sarcoidosis is a systemic granulomatous disease, frequently involving the lungs, lymph nodes, eyes and skin. Gastric sarcoidosis is very rare. We report three patients diagnosed initially with gastric sarcoidosis. Two had no other identified involvement, and one had involvement of the lungs and hilar lymph nodes. Gastroscopy was performed because of abdominal discomfort or as a follow-up examination for partial gastrectomy. This revealed atrophic lesions with nodular mucosal changes in the antrum and granular mucosa, and residual gastritis was found at the site of gastroduodenal anastomosis. Non-caseating epitheloid-cell granulomas were found in all patients following histological analysis. Gastroscopy and histopathological findings in gastric mucosal biopsy samples from suspicious sites are essential in establishing an accurate diagnosis of gastric sarcoidosis.


Journal of International Medical Research | 2006

Angiotensin-II Receptor Antagonist Alleviates Non-alcoholic Fatty Liver in KKAy Obese Mice with Type 2 Diabetes

F Yu; Takashi Takahashi; Junji Moriya; Ken Kawaura; J Yamakawa; K Kusaka; T Itoh; Hiroyuki Sumino; Shigeto Morimoto; Tsugiyasu Kanda

We examined the effects of the angiotensin-II receptor antagonist candesartan on non-alcoholic fatty liver (NAFL) and circulating adiponectin concentrations in KKAy obese mice with type 2 diabetes mellitus. The KKAy mice were randomly assigned to receive either candesartan at a once-daily dose of 10 mg/kg (n = 5) or placebo (n = 5). The differences in liver weight, histological evaluation of hepatic lipid infiltration, serum adiponectin concentration and hepatic adiponectin mRNA levels between the two groups were determined on day 7 after treatment was initiated. Candesartan-treated mice demonstrated significantly lower liver weights and reduced lipid droplets in hepatic cells compared with control mice. The circulating adiponectin levels and hepatic expression of adiponectin mRNA were significantly higher in candesartan-treated mice than control mice. These results suggest that candesartan might alleviate NAFL through elevation of circulating adiponectin levels in KKAy obese mice with type 2 diabetes mellitus.


Pathobiology | 2007

The Lymphatic Infiltration Identified by D2-40 Monoclonal Antibody Predicts Lymph Node Metastasis in Submucosal Invasive Colorectal Cancer

Ken Kawaura; Satoshi Fujii; Yukinori Murata; Takahiro Hasebe; Genichiro Ishii; Tohru Itoh; Yasushi Sano; Norio Saito; Atsushi Ochiai

Background and Study Aims: Lymphatic infiltration has been recognized as a significant risk factor for lymph node metastasis of submucosal invasive colorectal cancer (SICC), but it is difficult to detect microscopically on hematoxylin and eosin (H&E)-stained slides. We therefore identified lymphatic infiltration of tumor cells with D2-40 monoclonal antibody, which reacts specifically against the endothelium of lymphatic vessels, to make an objective and precise diagnosis. Patients and Methods: The surgical specimens of 122 consecutive patients with nonpedunculated SICC were examined for lymphatic infiltration by immunohistochemical staining with D2-40 monoclonal antibody (LI-D) and for venous infiltration by Elastica van Gieson staining (VI-E). Results: Lymph node metastasis was found in 20 patients. Multivariate analysis showed that LI-D (p = 0.0415) and VI-E (p = 0.0119) were significant risk factors for lymph node metastasis. Regardless of the presence of risk factors including at least either lymphatic infiltration or venous infiltration, no lymph node metastasis-positive patients were found (0%) among the 25 patients whose colorectal cancer had a submucosal invasive depth of less than 1,500 µm. No lymph node metastasis was found in any of the patients with a depth of submucosal invasion of less than 3,000 µm, who had no risk factors, including LI-D or VI-E. Conclusions: Correct evaluation of lymphatic infiltration by immunohistochemical staining with D2-40 monoclonal antibody may play a crucial role in determining whether there are indications for additional treatment in the management of endoscopically resected SICC.


Journal of International Medical Research | 2004

Chronotropic Effect of the Antithrombotic Agent Cilostazol in a Patient with Sick Sinus Syndrome and Syncope

Junji Moriya; Takashi Takahashi; Y Nomura; Ken Kawaura; K Kusaka; J Yamakawa; N Fujioka; S Okubo; T Itoh; Tsugiyasu Kanda

In this case report we describe an 80-year-old man with sick sinus syndrome (SSS) who developed syncope attacks. The diagnosis of SSS was based on electrocardiographic evidence of markedly prolonged sinus arrests associated with syncope attacks while in hospital. The patient was given cilostazol, an anti-thrombotic agent that selectively inhibits cyclic nucleotide phosphodiesterase type 3, at a dose of 100 mg twice daily. The syncope attacks ceased, and an electrocardiogram obtained 1 week after the start of cilostazol administration showed no evidence of sinus arrest. The outcome of this case suggests that cilostazol may be useful in patients with syncope attacks due to SSS, although the long-term chronotropic effects of cilostazol need to be evaluated.


Journal of International Medical Research | 2003

Brugada-Like Electrocardiographic Changes during Influenza Infection

K Kusaka; J Yamakawa; Ken Kawaura; T Itoh; Takashi Takahashi; R Ishii; Tsugiyasu Kanda

We describe a 32-year-old man with electrocardiographic (ECG) changes consistent with Brugada syndrome and influenza virus infection. The ECG pattern changed after 1 week to one of early repolarization in V1 and V2. This case suggests an association between Brugada syndrome and viral infection.


Journal of Digestive Diseases | 2016

Findings of the margin around lesions by magnifying endoscopy with narrow-band imaging in early gastric carcinoma and intestinal metaplasia.

Kazu Hamada; Tohru Itoh; Ken Kawaura; Sadafumi Azukisawa; Rika Kobayashi; Hideyuki Okamura; Hidekazu Kitakata; Sachio Urashima; Takayuki Nojima; Masayuki A Fujino

Many endoscopists have reported their own classifications of early gastric carcinoma (EGC) using magnifying narrow‐band imaging (M‐NBI). However, few reports on classifying the margin around lesions by M‐NBI have been published. The aim of this study was to advocate the usefulness of the demarcation area classification for the diagnosis of EGC.

Collaboration


Dive into the Ken Kawaura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tsugiyasu Kanda

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

K Kusaka

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

J Yamakawa

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

T Itoh

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Junji Moriya

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Tohru Itoh

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Seiichiro Saegusa

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Jun-ichi Yamakawa

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Shigeto Morimoto

Kanazawa Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge